Page last updated: 2024-11-05

trifluoperazine and Cardiovascular Diseases

trifluoperazine has been researched along with Cardiovascular Diseases in 3 studies

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zolotnitskii, RI1
Kutsenok, BM1
Gastev, MD1
Bellia, P1
Landolina, F1
Tomasello, A1
Schleef, G1

Other Studies

3 other studies available for trifluoperazine and Cardiovascular Diseases

ArticleYear
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1969, Volume: 69, Issue:5

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall

1969
[Action of some phenothiazine neuroleptics on the cardiovascular system].
    Atti della Societa italiana di cardiologia, 1969, Jan-21, Volume: 2

    Topics: Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Diseases; Electrocardiography; Heart Rate; Huma

1969
[Experiences with neuroleptic Jatroneural-retard].
    Therapie der Gegenwart, 1970, Volume: 109, Issue:5

    Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Female; Humans; Male; Middle Aged; Neurasth

1970